Representative before the EPO

Company dna fry heath and spence llp
no operation time available
3 offices
active in Legal Services

Representative before the EPO

Employment test 51 - 200 employees
Company dna kilburn and strode llp
operating since 1906
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 5 EP applications Catherine Katzka has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12847122

TREATMENT REGIMENS USING MULTIPLE PHARMACEUTICAL AGENTS

IPC classification:
C07D 487/00
Applicant:
Intellikine LLC
Agent:
Catherine Katzka, Kilburn & Strode LLP
Status:
GRANT OF PATENT INTENDED
EP12847622

COMBINATION OF KINASE INHIBITORS AND USES THEREOF

IPC classification:
G01N 33/574
Applicant:
Intellikine LLC
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP12846964

KINASE INHIBITOR POLYMORPHS

IPC classification:
C07D 413/00
Applicant:
Intellikine LLC
Agent:
Multiple attorneys, Kilburn & Strode LLP
Status:
EXAMINATION IN PROGRESS
EP12851302

HETEROCYCLIC COMPOUNDS AND USES THEREOF

IPC classification:
A61K 31/4375, C07D 471/04, C07D 263/58, C07D 263/54
Applicant:
Intellikine LLC
Agent:
Catherine Katzka, Kilburn & Strode LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15155832

Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof

IPC classification:
C07D 487/04, A61K 31/553, C07D 471/04
Agent:
Catherine Katzka, Kilburn & Strode LLP
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature